Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.

KPV is a tripeptide NF-κB inhibitor with anti-inflammatory and immune-tolerance-promoting properties. Standard dosage: 200-500 mcg daily. Most experience improvement within 2-4 weeks, maximal effects by 8-12 weeks. Safety profile is favorable; serious adverse events are not documented.

What is KPV in simple terms?

KPV (Lysine-Proline-Valine) is a small peptide made of three amino acids. It reduces inflammation in the intestines and modulates immune responses toward tolerance. It's derived from a natural hormone called alpha-MSH. Research suggests it helps with inflammatory bowel disease, intestinal barrier dysfunction, and immune-related conditions.

How long before I see results?

Most see initial improvement within 2-4 weeks. Maximum benefit typically occurs by 8-12 weeks. A 12-week trial is recommended minimum to assess efficacy.

Is KPV natural?

KPV is derived from alpha-MSH, a natural hormone your body produces. However, the pharmaceutical-grade KPV used therapeutically is synthesized in laboratories, not extracted from natural sources.

Can I use KPV with other medications?

Most medications are compatible with KPV. Medical consultation is important, particularly with immunosuppressive drugs. Standard IBD medications can be combined with KPV.

What makes KPV different from other anti-inflammatory peptides?

KPV's selective NF-κB inhibition and immune tolerance promotion differ from broader immunosuppressants. Unlike some peptides, KPV preserves antimicrobial immunity. It promotes healing alongside inflammation suppression.

How do I know if I'm responding to KPV?

Objective measures: decreased diarrhea frequency, reduced abdominal pain, cessation of bleeding, improved laboratory markers (fecal calprotectin, CRP, hemoglobin). Subjective: increased energy, improved quality-of-life, resumed activities. Combination of objective and subjective improvement indicates response.

Can women take KPV while pregnant?

Unknown in humans. Preclinical data are favorable. Medical consultation is essential—pregnancy is conservative time for novel therapies. Discuss with healthcare provider before continuing or starting KPV during pregnancy.

Is KPV expensive?

Typically $100-300/month depending on dose and supplier. More expensive than generic medications but less than biological therapies. Cost varies based on formulation and compounder.

Where do I access KPV?

Through medical practitioners and licensed pharmaceutical compounders. Physicians can prescribe; compounders prepare. Clinical trial participation is alternative access route. Avoid unlicensed online suppliers.

How long should I use KPV?

Some discontinue after 6-12 months if disease is controlled and other factors optimized. Others require indefinite maintenance with cycling protocols. Medical practitioner guidance determines appropriate duration.

Will KPV make me immune-deficient?

No. KPV promotes immune tolerance rather than suppression. Antimicrobial immunity is preserved. Infection rates don't increase. Lymphocyte counts typically remain stable or increase.

Can I adjust my KPV dose?

Yes, with medical guidance. Dose optimization through titration is standard practice. Start conservative, increase by 25-50% based on response and tolerability.

Vendors

Ascension

Visit

Particle

Visit

Limitless

Visit

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Particle Peptides

Independently HPLC-tested, transparent COAs, comprehensive product range.

Browse Particle Peptides →

Limitless Life Nootropics

Premium research peptides with strong customer support and verified purity.

Browse Limitless Life →

FAQ

What is KPV?

Lysine-Proline-Valine tripeptide inhibiting NF-κB and promoting immune tolerance.

How much does it cost?

$100-300/month from licensed compounders.

Is it safe?

Yes. Favorable preclinical and early human data. No serious adverse events documented.

Where do I buy it?

Through medical practitioners and licensed pharmaceutical compounders.

How long until results?

2-4 weeks initial improvement, 8-12 weeks maximal effect.

Can it replace IBD meds?

Not reliably. Combination therapy typically outperforms monotherapy.